Related Experiment Video
Updated: May 22, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Acute stroke management in patients taking dabigatran
Raf Brouns1, Robbert-Jan Van Hooff, Ann De Smedt
1Department of Neurology, Universitair Ziekenhuis Brussel, Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium. raf.brouns@uzbrussel.be
CNS Neuroscience & Therapeutics
|April 27, 2012
Summary
Dabigatran etexilate offers an alternative to vitamin K antagonists, but lacks management guidelines for stroke patients. This review provides practical approaches for managing bleeding and stroke in patients taking dabigatran.
Area of Science:
- Neurology
- Pharmacology
- Cardiology
Background:
- Dabigatran etexilate is a novel oral anticoagulant gaining traction as an alternative to vitamin K antagonists.
- Current evidence-based guidelines for managing intracerebral hemorrhage and acute ischemic stroke in patients on dabigatran are lacking.
- This knowledge gap necessitates a review of dabigatran's properties and management strategies.
Purpose of the Study:
- To summarize current knowledge on dabigatran etexilate's pharmacological features.
- To review methods for assessing dabigatran activity.
- To provide pragmatic approaches for managing acute stroke and bleeding in patients taking dabigatran.
Main Methods:
- Literature review of pharmacological properties of dabigatran.
- Summary of current methods for assessing dabigatran levels.
- Development of practical recommendations for clinical decision-making.
Main Results:
- Dabigatran etexilate has distinct pharmacokinetic and pharmacodynamic profiles.
- Assessment of dabigatran activity can be achieved through specific laboratory tests.
- Individualized strategies for hemostatic therapy and reperfusion are crucial.
Conclusions:
- Management of stroke and bleeding in dabigatran-treated patients requires tailored approaches.
- Understanding dabigatran's pharmacology is key to safe and effective patient care.
- Further research and guideline development are warranted for this emerging anticoagulant.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...